![](/img/cover-not-exists.png)
Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell disease
Bhatia, M, Jin, Z, Baker, C, Geyer, M B, Radhakrishnan, K, Morris, E, Satwani, P, George, D, Garvin, J, Del Toro, G, Zuckerman, W, Lee, M T, Licursi, M, Hawks, R, Smilow, E, Baxter-Lowe, L A, SchwartzVolume:
49
Language:
english
Journal:
Bone Marrow Transplantation
DOI:
10.1038/bmt.2014.84
Date:
July, 2014
File:
PDF, 739 KB
english, 2014